Chemed CorporationCHENYSE
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +7.38% | +9.23% | +9.79% | +3.85% | +3.09% |
| Gross Profit Growth | +3.87% | +2.88% | +6.03% | -10.40% | -13.96% |
| EBITDA Growth | +7.39% | +3.79% | +11.22% | -20.14% | -13.12% |
| Operating Income Growth | +6.11% | +2.23% | +31.00% | -22.74% | -18.89% |
| Net Income Growth | +1.09% | +0.30% | +10.37% | -25.95% | -15.23% |
| EPS Growth | +1.41% | +2.01% | +14.19% | -23.40% | -11.51% |
| EPS Diluted Growth | +1.83% | +2.03% | +14.62% | -23.23% | -11.16% |
| Weighted Average Shares Growth | -0.33% | -1.63% | -3.30% | -3.25% | -3.26% |
| Weighted Average Shares Diluted Growth | -0.78% | -1.82% | -3.75% | -4.23% | -3.63% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +212.92% | +51.91% | -61.27% | +78.81% | -7.88% |
| Free Cash Flow Growth | +345.65% | +57.21% | -73.11% | +84.78% | -14.22% |
| Receivables Growth | +16.93% | -5.70% | +61.21% | -0.04% | +9.72% |
| Inventory Growth | -20.88% | -31.75% | -27.28% | -14.78% | -16.78% |
| Asset Growth | +13.27% | +0.03% | -0.06% | -0.99% | -8.24% |
| Book Value per Share Growth | +21.65% | +2.68% | +3.26% | +2.61% | -9.94% |
| Debt Growth | +7.99% | -9.20% | -0.74% | -0.57% | -4.35% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +2.39% | +3.80% | -8.88% | -0.21% | +3.72% |